title: Authors' response to: Statins in pregnancy: safety and perspectives of therapeutic applications.
authors.affiliation: STIS and Division of Clinical Pharmacology and Toxicology, University Hospital, Lausanne, Switzerland.
authors.forename: U
authors.initials: U
authors.lastname: Winterfeld
authors.forename: A
authors.initials: A
authors.lastname: Allignol
authors.forename: A
authors.initials: A
authors.lastname: Panchaud
authors.forename: L E
authors.initials: LE
authors.lastname: Rothuizen
authors.forename: P
authors.initials: P
authors.lastname: Merlob
authors.forename: B
authors.initials: B
authors.lastname: Cuppers-Maarschalkerweerd
authors.forename: T
authors.initials: T
authors.lastname: Vial
authors.forename: S
authors.initials: S
authors.lastname: Stephens
authors.forename: M
authors.initials: M
authors.lastname: Clementi
authors.forename: M
authors.initials: M
authors.lastname: De Santis
authors.forename: A
authors.initials: A
authors.lastname: Pistelli
authors.forename: M
authors.initials: M
authors.lastname: Berlin
authors.forename: G
authors.initials: G
authors.lastname: Eleftheriou
authors.forename: E
authors.initials: E
authors.lastname: Maňáková
authors.forename: T
authors.initials: T
authors.lastname: Buclin
mesh_terms: D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects*; D018811:Maternal Exposure / Q000009:adverse effects*; D011247:Pregnancy; D011256:Pregnancy Outcome / Q000453:epidemiology*; D013723:Teratogens
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D013723:Teratogens